157 related articles for article (PubMed ID: 6796530)
1. Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report.
Mulé JJ; Forstrom JW; George E; Hellström I; Hellström KE
Int J Cancer; 1981 Nov; 28(5):611-4. PubMed ID: 6796530
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
Hellström KE; Hellström I
Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
[TBL] [Abstract][Full Text] [Related]
3. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY; Smyth MJ; Godfrey DI
J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
[TBL] [Abstract][Full Text] [Related]
4. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
6. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
7. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
[TBL] [Abstract][Full Text] [Related]
9. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
[TBL] [Abstract][Full Text] [Related]
10. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
[TBL] [Abstract][Full Text] [Related]
11. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
Engel AM; Svane IM; Rygaard J; Werdelin O
Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
[TBL] [Abstract][Full Text] [Related]
12. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
Kadhim SA; Rees RC; Barrington-Leigh J
Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
[TBL] [Abstract][Full Text] [Related]
13. Antibody response of mice to chemically induced tumors.
Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
[TBL] [Abstract][Full Text] [Related]
14. In vitro demonstration of cryosurgical augmentation of tumor immunity.
Faraci RP; Bagley DH; Marrone J; Beazley RM
Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
[TBL] [Abstract][Full Text] [Related]
15. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
16. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
Röllinghoff M; Warner NL
Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
[No Abstract] [Full Text] [Related]
17. Immune selection in murine tumors. A study of MCA induced sarcomas in normal and immunodeficient mice.
Engel AM; Svane IM; Rygaard J; Werdelin O
Folia Microbiol (Praha); 1998; 43(5):483-6. PubMed ID: 9821304
[No Abstract] [Full Text] [Related]
18. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
[TBL] [Abstract][Full Text] [Related]
19. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated suppression of tumor immunity has a non-specific component. II. Evidence from cell culture experiments.
Hellström I; Hellström KE
Int J Cancer; 1981; 27(4):487-91. PubMed ID: 6168592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
